AACR Applauds Confirmation of Robert M. Califf, MD, as FDA Commissioner
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner PHILADELPHIA — The American...
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner PHILADELPHIA — The American...
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Raymond N. DuBois, MD, PhD, FAACR, on his...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19...
WASHINGTON, DC – Today, American Association for Cancer Research (AACR) CEO Margaret Foti, PhD, MD (hc), issued the following...
PHILADELPHIA – Compared to U.S. urban adults, rural adults were more likely to think fatalistically about cancer and feel...
Risk may be greatest among young Black and Hispanic subgroups PHILADELPHIA – Individuals between 20 and 39 years old...
Findings have implications for future cancer clinical trial design involving immune checkpoint inhibitors PHILADELPHIA – Independent drug action, not...
Study reports progressive improvement in the outcomes of patients carrying the Philadelphia chromosome PHILADELPHIA – For patients with acute...
Resource reflects transition from a mostly microscopy-driven to a molecularly driven classification system PHILADELPHIA – The first classification of...
SAN ANTONIO – Among patients with previously treated HER2-positive metastatic breast cancer, those who received pyrotinib plus capecitabine had...